Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from DENTSPLY SIRONA ( (XRAY) ) is now available.
On October 31, 2025, DENTSPLY SIRONA Inc. announced that Matthew E. Garth will step down from his role as Executive Vice President and Chief Financial Officer, effective November 5, 2025. The company has begun searching for a new CFO and clarified that Garth’s departure is not due to any disagreements regarding the company’s financial practices. Concurrently, Daniel T. Scavilla, the company’s President and CEO, will take on the additional role of interim principal financial officer. This transition is not expected to involve any new compensatory arrangements for Scavilla.
The most recent analyst rating on (XRAY) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score is primarily impacted by its financial performance challenges, including declining revenue and increased leverage. The technical analysis provides mixed signals, with bearish momentum and potential overbought conditions. The valuation reflects financial struggles with a negative P/E ratio, but the high dividend yield offers some appeal. The earnings call provided some positive insights, such as improved margins, but overall sentiment remains cautious due to sales declines and impairment charges.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
Average Trading Volume: 3,260,002
Technical Sentiment Signal: Sell
Current Market Cap: $2.49B
See more data about XRAY stock on TipRanks’ Stock Analysis page.